Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zoran Rankovic

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
ACS Chemical Biology|June 1, 2023
Design of Class I/IV Bromodomain-Targeting Degraders for Chromatin Remodeling ComplexesHuda Zahid, Jeff P Costello, Yao Li, et al.
European Journal of Medicinal Chemistry|January 7, 2019
Identification of substituted 5-membered heterocyclic compounds as potential anti-leukemic agentsTaotao Ling, Julie Maier, Sourav Das, et al.
Cell Death and Differentiation|June 21, 2022
Ca<sup>2+</sup>-mediated mitochondrial inner membrane permeabilization induces cell death independently of Bax and BakGiovanni Quarato, Fabien Llambi, Cliff S Guy, et al.
Journal of Medicinal Chemistry|August 10, 2018
Development of Second-Generation CDK2 Inhibitors for the Prevention of Cisplatin-Induced Hearing LossRobert A Hazlitt, Tal Teitz, Justine D Bonga, et al.
Bioorganic & Medicinal Chemistry Letters|February 16, 2010
Dioxo-triazines as a novel series of cathepsin K inhibitorsZoran Rankovic, Jiaqiang Cai, Xavier Fradera, et al.
Biorxiv : the Preprint Server for Biology|July 17, 2025
LCK-targeting molecular glues overcome resistance to inhibitor-based therapy in T-cell acute lymphoblastic leukemiaJun J Yang, Gisele Nishiguchi, Satoshi Yoshimura, et al.
Blood|June 5, 2026
LCK-targeting molecular glues overcome resistance to inhibitor-based therapy in T-cell acute lymphoblastic leukemiaJun J Yang, Satoshi Yoshimura, Marisa Actis, et al.
Journal of Medicinal Chemistry|July 8, 2024
Development of an Orally Bioavailable LCK PROTAC Degrader as a Potential Therapeutic Approach to T-Cell Acute Lymphoblastic LeukemiaJamie A Jarusiewicz, Satoshi Yoshimura, Marisa Actis, et al.
Iscience|September 23, 2022
Small molecule SJ572946 activates BAK to initiate apoptosisGiridhar Sekar, Geetika Singh, Xingping Qin, et al.
ACS Medicinal Chemistry Letters|June 25, 2025
HTS Identifies NUP98-KDM5A-PHD3 Domain Ligands with Novel ScaffoldsWenwei Lin, P Jake Slavish, Aaron H Phillips, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
ACS Chemical Biology|June 1, 2023
Design of Class I/IV Bromodomain-Targeting Degraders for Chromatin Remodeling ComplexesHuda Zahid, Jeff P Costello, Yao Li, et al.
European Journal of Medicinal Chemistry|January 7, 2019
Identification of substituted 5-membered heterocyclic compounds as potential anti-leukemic agentsTaotao Ling, Julie Maier, Sourav Das, et al.
Cell Death and Differentiation|June 21, 2022
Ca<sup>2+</sup>-mediated mitochondrial inner membrane permeabilization induces cell death independently of Bax and BakGiovanni Quarato, Fabien Llambi, Cliff S Guy, et al.
Journal of Medicinal Chemistry|August 10, 2018
Development of Second-Generation CDK2 Inhibitors for the Prevention of Cisplatin-Induced Hearing LossRobert A Hazlitt, Tal Teitz, Justine D Bonga, et al.
Bioorganic & Medicinal Chemistry Letters|February 16, 2010
Dioxo-triazines as a novel series of cathepsin K inhibitorsZoran Rankovic, Jiaqiang Cai, Xavier Fradera, et al.
Biorxiv : the Preprint Server for Biology|July 17, 2025
LCK-targeting molecular glues overcome resistance to inhibitor-based therapy in T-cell acute lymphoblastic leukemiaJun J Yang, Gisele Nishiguchi, Satoshi Yoshimura, et al.
Blood|June 5, 2026
LCK-targeting molecular glues overcome resistance to inhibitor-based therapy in T-cell acute lymphoblastic leukemiaJun J Yang, Satoshi Yoshimura, Marisa Actis, et al.
Journal of Medicinal Chemistry|July 8, 2024
Development of an Orally Bioavailable LCK PROTAC Degrader as a Potential Therapeutic Approach to T-Cell Acute Lymphoblastic LeukemiaJamie A Jarusiewicz, Satoshi Yoshimura, Marisa Actis, et al.
Iscience|September 23, 2022
Small molecule SJ572946 activates BAK to initiate apoptosisGiridhar Sekar, Geetika Singh, Xingping Qin, et al.
ACS Medicinal Chemistry Letters|June 25, 2025
HTS Identifies NUP98-KDM5A-PHD3 Domain Ligands with Novel ScaffoldsWenwei Lin, P Jake Slavish, Aaron H Phillips, et al.
Pageof 7